The IBN SINA Pharmaceutical Industry PLC reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported sales was BDT 2,895.53 million compared to BDT 2,454.98 million a year ago. Net income was BDT 162.85 million compared to BDT 144.53 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
252.7 BDT | -0.32% | -1.52% | -11.83% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.83% | 67.59M | |
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- IBNSINA Stock
- News The IBN SINA Pharmaceutical Industry PLC
- The IBN SINA Pharmaceutical Industry PLC Reports Earnings Results for the First Quarter Ended September 30, 2023